Jim Cramer Gives Green Light To This Health Care Stock

Jim Cramer advised against investing in Apple Hospitality REIT (NYSE: APLE) due to rising interest rates, suggesting potential losses. He expressed a preference for Jazz Pharmaceuticals (NASDAQ: JAZZ), which RBC Capital maintains an Outperform rating on, although the price target was slightly reduced from $299 to $296. Cramer also noted a recent spin-off of Corteva's seed and genetics business into Vylor (NYSE: VYLR) and mentioned EchoStar (NASDAQ: ECHO) as a potential acquisition target for SpaceX. On the market front, Corteva shares fell 3.7%, while Onto Innovation shares rose 0.6% and Jazz Pharmaceuticals dropped 1.8%.